Upregulation of MMP-2 by HMGA1 Promotes Transformation in Undifferentiated, Large-Cell Lung Cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Cancer Research

• Publication date

  2009-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-08-0336PMID 19903768PMCID PMC3069640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between Matrix Metalloproteinase 2 and Lung Cancer Progression

  2012cited by this paper
• HMGA1 Correlates with Advanced Tumor Grade and Decreased Survival in Pancreatic Ductal Adenocarcinoma

  2009cited by this paper
• Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma

  2009cited by this paper
• HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma

  2009cited by this paper
• Cancer invasion and metastasis: changing views

  2008influential reference
• The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?

  2008cited by this paper
• The HMGA1a-STAT3 axis: an “Achilles Heel” for Hematopoietic Malignancies Overexpressing HMGA1a?

  2008cited by this paper
• An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

  2008cited by this paper
• The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.

  2007cited by this paper
• Roles of HMGA proteins in cancer

  2007influential reference
• Increased expression of high mobility group A proteins in lung cancer

  2006cited by this paper
• Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

  2006cited by this paper
• HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.

  2006cited by this paper
• Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy

  2006influential reference
• Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas

  2005cited by this paper
• CCAAT/Enhancer Binding Protein α (C/EBPα) and C/EBPα Myeloid Oncoproteins Induce Bcl-2 via Interaction of Their Basic Regions with Nuclear Factor-κB p50

  2005cited by this paper
• RPL38, FOSL1, and UPP1 Are Predominantly Expressed in the Pancreatic Ductal Epithelium

  2005cited by this paper
• Urological Survey UROLOGICAL ONCOLOGY: PROSTATE CANCER Hedgehog Signalling in Prostate Regeneration, Neoplasia and Metastasis

  2005cited by this paper
• CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.

  2005cited by this paper
• Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells

  2004cited by this paper
• High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase‐2 expression in prostate cancer cells

  2004cited by this paper
• The HMG-I Oncogene Causes Highly Penetrant, Aggressive Lymphoid Malignancy in Transgenic Mice and Is Overexpressed in Human Leukemia

  2004cited by this paper
• HMG-I/Y in human breast cancer cell lines

  2002influential reference
• New functions for the matrix metalloproteinases in cancer progression

  2002influential reference
• Focus on lung cancer.

  2002cited by this paper
• Molecular biology of HMGA proteins: hubs of nuclear function.

  2001influential reference
• Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells

  2001cited by this paper
• HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene

  2000influential reference
• Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

  2000influential reference
• The oncogenic properties of the HMG-I gene family.

  2000influential reference
• Overexpression of Matrix Metalloproteinase 2 Predicts Unfavorable Outcome in Early-Stage Non-Small Cell Lung Cancer 1

  2000cited by this paper
• Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer.

  2000cited by this paper
• Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.

  2000cited by this paper
• Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins

  1999cited by this paper
• Serial analysis of gene expression in non-small cell lung cancer.

  1998cited by this paper
• Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP)*

  1998cited by this paper
• Characterization of Encephalitozoon (Septata) intestinalis Isolates Cultured from Nasal Mucosa and Bronchoalveolar Lavage Fluids of Two AIDS Patients

  1996influential reference
• Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2.

  1996cited by this paper
• The molecular and cellular basis of human lung cancer.

  1994cited by this paper
• Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene.

  1993cited by this paper
• Human pleural effusions are rich in matrix metalloproteinases.

  1992cited by this paper
• Chromosomal localization of the murine gene and two related sequences encoding high-mobility-group I and Y proteins.

  1992cited by this paper
• Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein.

  1991cited by this paper
• Peripheral airway cell differentiation in human lung cancer cell lines.

  1990cited by this paper
• Structure of the human type IV collagenase gene.

  1990cited by this paper
• Structural features of the HMG chromosomal proteins and their genes.

  1990cited by this paper
• Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.

  1986cited by this paper
• Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.

  1985influential reference
• Establishment and identification of small cell lung cancer cell lines having classic and variant features.

  1985influential reference
• On the presence of two new high mobility group‐like proteins in HeLa S3 cells

  1983cited by this paper
• Establishment and characterization of a continuous lung squamous cell carcinoma cell line (U-1752).

  1981cited by this paper
• One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

  1977cited by this paper

• HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis

  2025cites this paper
• High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression

  2025cites this paper
• Polypyrimidine tract-binding protein 3/insulin-like growth factor 2 mRNA-binding proteins 3/high-mobility group A1 axis promotes renal cancer growth and metastasis

  2024cites this paper
• IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma.

  2024cites this paper
• Increased heterogeneity in expression of genes associated with cancer progression and drug resistance

  2024cites this paper
• HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation

  2023cites this paper
• The multifaceted roles of matrix metalloproteinases in lung cancer

  2023cites this paper
• TFAP2A activates HMGA1 to promote glycolysis and lung adenocarcinoma progression.

  2023cites this paper
• Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression

  2023cites this paper
• Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis

  2022cites this paper
• HMGA1 Chromatin Regulators Induce Transcriptional Networks Involved in GATA2 and Proliferation During MPN Progression.

  2022cites this paper
• The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1

  2022cites this paper
• HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report

  2022cites this paper
• Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer

  2022cites this paper
• Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma

  2022cites this paper
• Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy

  2021cites this paper
• Deregulation of a Cis-Acting lncRNA in Non-small Cell Lung Cancer May Control HMGA1 Expression

  2021cites this paper
• HMGA1 promotes gastric cancer growth and metastasis by transactivating SUZ12 and CCDC43 expression

  2021cites this paper
• EZH2-mediated SLC7A11 upregulation via miR-125b-5p represses ferroptosis of TSCC.

  2021cites this paper
• Polymorphism and expression of the HMGA1 gene and association with tail fat deposition in Hu sheep

  2021cites this paper
• HMGA1 Is a Potential Driver of Preeclampsia Pathogenesis by Interference with Extravillous Trophoblasts Invasion

  2021cites this paper
• Alteration of non-coding RNAs as a mechanism of lung cancer gene deregulation

  2020cites this paper
• GRP75-Upregulated HMGA1 Expression Promotes Stage I Lung Adenocarcinoma Progression by Activating the JNK/c-JUN Signaling Pathway

  2020cites this paper
• High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer

  2019cites this paper
• Regulatory Network Analysis to Reveal Important miRNAs and Genes in Non-Small Cell Lung Cancer

  2019cites this paper
• HMGA1 in cancer: Cancer classification by location

  2019cites this paper
• HMGA and Cancer: A Review on Patent Literatures.

  2019cites this paper
• Falling from grace: HPRT is not suitable as an endogenous control for cancer-related studies

  2019cites this paper
• The Clinical Significance of HPRT as a Diagnostic and Therapeutic Biomarker for Hematological and Solid Malignancies

  2018cites this paper
• RETRACTED ARTICLE: HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer

  2018cites this paper
• Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.

  2018cites this paper
• HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.

  2018cites this paper
• microRNA-98 inhibits the proliferation, invasion, migration and promotes apoptosis of breast cancer cells by binding to HMGA2

  2018cites this paper
• Elevated Expression of Hypoxanthine Guanine Phosphoribosyltransferase within Malignant Tissue

  2017cites this paper
• TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion

  2017cites this paper
• Bioinformatics strategies for identification of cancer biomarkers and targets in pathogens associated with cancer

  2017cites this paper
• HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells

  2017cites this paper
• Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer

  2017cites this paper
• HMGA1-pseudogenes and cancer

  2016cites this paper
• HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models1

  2016cites this paper
• Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.

  2016cites this paper
• The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

  2016cites this paper
• The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.

  2016cites this paper
• Systems Biology of Transcription Regulation

  2016cites this paper
• Computational Detection of Stage-Specific Transcription Factor Clusters during Heart Development

  2016cites this paper
• RNA-Mediated Regulation of HMGA1 Function

  2015cites this paper
• Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms

  2015cites this paper
• Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.

  2015cites this paper
• RNA-Mediated Regulation of HMGA1 Function.

  2015cites this paper
• Increases urinary HMGA1 in serous epithelial ovarian cancer patients

  2015cites this paper
• Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression.

  2014cites this paper
• The high mobility group A1 molecular switch: turning on cancer – can we turn it off?

  2014influential citation
• Role of miRNA Let-7 and Its Major Targets in Prostate Cancer

  2014cites this paper
• Analysis of the Genome Stability of Uterine Fibroids with Different Degree of HMGA Expression

  2013cites this paper
• HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells

  2013cites this paper
• Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis

  2013cites this paper
• Expression of HMGA1 and Ezrin in laryngeal squamous cell carcinoma

  2013cites this paper
• Hitting the bull’s eye: targeting HMGA1 in cancer stem cells

  2013cites this paper
• Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.

  2013cites this paper
• Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer.

  2013cites this paper
• A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer

  2013cites this paper
• A Protein Array Screen for Kaposi's Sarcoma-Associated Herpesvirus LANA Interactors Links LANA to TIP60, PP2A Activity, and Telomere Shortening

  2012influential citation
• A seed-based approach to identify risk disease sub-networks in human lung cancer

  2012cites this paper
• CancerMA: a web-based tool for automatic meta-analysis of public cancer microarray data

  2012cites this paper
• Development of a bioinformatic analytical approach to identify novel human cancer testis gene candidates

  2012influential citation
• A Novel MMP-2 Inhibitor 3-azidowithaferin A (3-azidoWA) Abrogates Cancer Cell Invasion and Angiogenesis by Modulating Extracellular Par-4

  2012cites this paper
• Transplantation Statins and the Risk of Cancer After Heart Transplantation

  2012cites this paper
• Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma

  2012cites this paper
• followed by cytosine arabinoside and mitoxantrone for acute leukemias Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol

  2012cites this paper
• Statins and the Risk of Cancer After Heart Transplantation

  2012cites this paper
• HMGA1 Reprograms Somatic Cells into Pluripotent Stem Cells by Inducing Stem Cell Transcriptional Networks

  2012cites this paper
• Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

  2012cites this paper
• High mobility group A1 and cancer: potential biomarker and therapeutic target.

  2012influential citation
• The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.

  2012cites this paper
• Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer.

  2012cites this paper
• HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells

  2012influential citation
• Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias.

  2011cites this paper
• High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells

  2011cites this paper
• AKNA: Another AT-hook transcription factor “hooking-up” with inflammation

  2011cites this paper
• HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis

  2011cites this paper
• Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia

  2011cites this paper
• Matrix Metalloproteinases and Cancer Cell Invasion/Metastasis

  2010cites this paper
• Let-7 a inhibits growth and migration of breast cancer cells by targeting HMGA 1

  year unknowncites this paper